Pfizer’s COVID vaccine data raise some flags, analysts say, but not enough to scuttle an FDA nod arlene.weintraub Wed, 12/09/2020 – 10:06 More: Pfizer’s COVID vaccine data raise some flags, analysts say, but not enough to scuttle an FDA nod
read moreBack to beauty: Former Allergan chief Saunders scoops up aesthetics company in $1.1B deal bbulik Wed, 12/09/2020 – 10:00 More: Back to beauty: Former Allergan chief Saunders scoops up aesthetics company in .1B deal Source: fierce
read moreZUMA-12 phase II study is evaluating therapy as a first-line treatment for high-risk large B-cell lymphoma More: Gilead’s CAR T therapy Yescarta shows potential in new indication Source: News
read moreVaccine candidate previously scored fast-track and breakthrough therapy designations More: Pfizer’s pneumococcal disease vaccine scores FDA priority review Source: News
read moreAgreement will utilise RetinAI’s IT solutions and artificial intelligence tools to support projects in ophthalmology More: Novartis signs AI ophthalmology pact with RetinAI Source: News
read moreMeet the winners of the 2020 PharmaTimes Marketer of the Year, Communications Awards and Sales Awards More: Winners shine bright at PharmaTimes Awards Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals